查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1485240

電子處方市場 - 全球產業規模、佔有率、趨勢、機會和預測，按產品（解決方案）、服務、專業、交付模式、物質、地區和競爭細分，2019-2029F

E-Prescribing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Solutions ), Services, By Specialties, By Delivery Mode, By Substances, By Region and Competition, 2019-2029F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2023 年全球電子處方市場估值為 25.2 億美元，預計在預測期內將穩定成長，到 2029 年複合年成長率為 8.30%。患者護理。近年來獲得巨大關注的一項創新是電子處方或電子處方。隨著醫療保健提供者、藥房和患者越來越認知到其好處，全球電子處方市場一直在大幅成長。電子處方通常稱為電子處方，是一種數位解決方案，允許醫療保健提供者以電子方式產生處方單並將其傳輸到藥房。它取代了傳統的手寫或印刷的紙質處方，為藥物管理提供了更有效率、更準確的方法。電子處方涵蓋各個組成部分，包括處方創建、即時用藥歷史記錄訪問、用藥警報以及與電子健康記錄 (EHR) 的連接。

市場概況
預測期 2025-2029
2023 年市場規模 25.2億美元
2029 年市場規模 40.8億美元
2024-2029 年複合年成長率 8.30%
成長最快的細分市場 解決方案
最大的市場 北美洲

電子處方減少了用藥錯誤的可能性，例如字跡模糊和劑量不正確，從而提高了患者的安全性。它消除了手動輸入的需要並減輕了醫療保健專業人員的管理負擔，從而簡化了處方流程。電子處方系統通常具有使患者能夠接收用藥提醒並存取相關資訊的功能，從而有助於提高依從性。電子處方解決方案擴大與電子健康記錄整合，在照護端提供全面的患者資訊。許多國家的政府和監管機構鼓勵採用電子處方，以提高醫療保健品質並降低成本。

主要市場促進因素

增加政府措施和法規

提高效率和便利性

主要市場挑戰

實施障礙

資料隱私和安全

用藥錯誤和決策支持

主要市場趨勢

技術進步

細分市場洞察

產品洞察

專業見解

區域洞察

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：全球電子處方市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品（解決方案（整合解決方案、獨立解決方案）、服務（支援、實施、培訓、網路）
    • 按專業（腫瘤學、運動醫學、神經病學、心臟科、其他）
    • 依交付模式（基於 Web/雲端、內部部署）
    • 依物質分類（管理物質、非管理物質）
    • 按地區
    • 按公司分類 (2023)
  • 市場地圖
    • 按產品分類
    • 按專業
    • 按交付方式
    • 按物質分類
    • 按地區

第 5 章：亞太地區電子處方市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按專業
    • 按交付方式
    • 按物質分類
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 澳洲
    • 日本
    • 韓國

第 6 章：歐洲電子處方市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按專業
    • 按交付方式
    • 按物質分類
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 西班牙
    • 義大利
    • 英國

第 7 章：北美電子處方市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按專業
    • 按交付方式
    • 按物質分類
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第 8 章：南美洲電子處方市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按專業
    • 按交付方式
    • 按物質分類
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 9 章：中東和非洲電子處方市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按專業
    • 按交付方式
    • 按物質分類
    • 按國家/地區
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 10 章：市場動態

  • 促進要素
  • 挑戰

第 11 章：市場趨勢與發展

  • 最近的發展
  • 產品發布
  • 併購

第 12 章：全球電子處方市場：SWOT 分析

第 13 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第14章：競爭格局

  • Oracle Corp.
  • Veradigm LLC
  • Epic Systems Corporation
  • Athenahealth, Inc.
  • NextGen Healthcare, Inc.
  • McKesson Corporation
  • Surescripts, LLC
  • Change Healthcare LLC
  • Practice Fusion, Inc.
  • Networking Technology, Inc.

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 22466

Global E-Prescribing Market was valued at USD 2.52 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 8.30% through 2029. In the ever-evolving landscape of healthcare, technological advancements continue to shape the way medical professionals deliver patient care. One such innovation that has gained significant traction in recent years is electronic prescribing, or e-prescribing. The Global E-Prescribing Market has been experiencing substantial growth as healthcare providers, pharmacies, and patients increasingly recognize its benefits. Electronic prescribing, commonly referred to as e-prescribing, is a digital solution that allows healthcare providers to generate and transmit prescription orders electronically to pharmacies. It replaces traditional handwritten or printed paper prescriptions, offering a more efficient and accurate method for medication management. E-prescribing encompasses various components, including the creation of prescriptions, real-time medication history access, medication alerts, and connectivity to electronic health records (EHRs).

Market Overview
Forecast Period2025-2029
Market Size 2023USD 2.52 Billion
Market Size 2029USD 4.08 Billion
CAGR 2024-20298.30%
Fastest Growing SegmentSolutions
Largest MarketNorth America

E-prescribing reduces the potential for medication errors, such as illegible handwriting and incorrect dosages, resulting in improved patient safety. It streamlines the prescription process by eliminating the need for manual entry and reducing administrative burdens on healthcare professionals. E-prescribing systems often come with features that enable patients to receive medication reminders and access relevant information, contributing to improved adherence. E-prescribing solutions are increasingly integrated with electronic health records, providing comprehensive patient information at the point of care. Governments and regulatory bodies in many countries have encouraged the adoption of e-prescribing to enhance healthcare quality and reduce costs.

Key Market Drivers

Increasing Government Initiatives and Regulations

The global healthcare landscape is evolving at a rapid pace, with technological advancements playing a pivotal role in transforming the way medical services are delivered. One such technological revolution in healthcare is the adoption of electronic prescribing, commonly known as e-prescribing. E-prescribing is a digital solution that streamlines the prescription process, ensuring accuracy, efficiency, and patient safety. In recent years, the global e-prescribing market has witnessed substantial growth, largely fueled by increasing government initiatives and regulations aimed at enhancing healthcare quality and reducing medication errors.

The growth of the global e-prescribing market can be primarily attributed to the increasing support and guidance from governments and regulatory bodies. These initiatives aim to address various issues within the healthcare system, such as patient safety, healthcare quality, and cost containment. In the United States, the Centers for Medicare and Medicaid Services (CMS) introduced the Electronic Health Record (EHR) Incentive Program, commonly referred to as "Meaningful Use." This program provides financial incentives to healthcare providers who adopt and demonstrate the meaningful use of EHRs, including e-prescribing.

Various governments around the world have launched healthcare information technology (IT) initiatives to encourage the implementation of EHRs and e-prescribing systems, often providing financial incentives to healthcare organizations that comply. Regulatory bodies like The Joint Commission in the United States and similar organizations globally have recognized e-prescribing as a means to enhance patient safety, thereby encouraging its adoption by healthcare facilities. Governments have played a role in setting standards and promoting interoperability between healthcare systems, ensuring seamless data exchange between different stakeholders in the healthcare ecosystem.

Increased Efficiency and Convenience

One of the primary drivers of the global e-prescribing market is the significant improvement in efficiency it offers. Healthcare providers, including physicians, nurse practitioners, and other prescribers, can easily access patients' medical histories, insurance information, and preferred pharmacies. This information allows them to make informed decisions quickly and prescribe the most suitable medication, eliminating errors and ensuring patient safety. E-prescribing enables real-time communication with pharmacies, reducing waiting times for patients and enhancing overall healthcare delivery. E-prescribing plays a vital role in enhancing patient safety by reducing medication errors. The digitization of prescriptions minimizes the chances of misinterpretation or illegible handwriting, which can lead to adverse drug events. With e-prescribing, drug-drug interaction alerts and dosage recommendations are readily available, assisting prescribers in making informed decisions. This leads to a safer and more effective medication management process for patients.

The adoption of e-prescribing systems has streamlined healthcare workflows for both providers and pharmacies. Prescribers can quickly and accurately send prescriptions to pharmacies, eliminating the need for patients to carry physical prescriptions. Pharmacists, in turn, can efficiently process electronic prescriptions, reducing wait times and enhancing customer satisfaction. These streamlined processes have a significant impact on patient care and overall healthcare system efficiency.

Key Market Challenges

Implementation Barriers

One of the primary challenges faced by the e-prescribing market is the resistance to implementation. Transitioning from paper-based prescription systems to electronic prescribing requires significant investment in both technology and training. Healthcare providers, especially in smaller practices and rural areas, may find it challenging to adapt to new systems, which can lead to slower adoption rates. Moreover, interoperability issues between various electronic health record (EHR) systems and pharmacy software can hinder seamless information exchange. Ensuring that these systems can communicate effectively is crucial for the success of e-prescribing.

Data Privacy and Security

The healthcare industry, including e-prescribing, deals with sensitive patient information. The need to protect patient data from security breaches and unauthorized access is paramount. Healthcare providers and technology companies must invest in robust cybersecurity measures to safeguard electronic health records and prescription data. Compliance with stringent data protection regulations, such as the Health Insurance Portability and Accountability Act (HIPAA) in the United States, adds complexity to the e-prescribing landscape.

Medication Errors and Decision Support

While e-prescribing can reduce some medication errors associated with illegible handwriting, it introduces new challenges. Decision support tools embedded in e-prescribing systems may generate alerts and suggestions for healthcare providers, but these alerts can sometimes be overwhelming and lead to alert fatigue. Striking the right balance between providing useful guidance and avoiding excessive interruptions in the workflow of healthcare professionals is a significant challenge.

Key Market Trends

Technological Advancements

The global healthcare industry is undergoing a profound transformation, largely driven by the increasing adoption of advanced technologies. One of the significant technological advancements revolutionizing healthcare is e-prescribing, a practice that allows healthcare providers to electronically generate and send prescriptions to pharmacies. E-prescribing has come a long way since its inception in the early 2000s. What started as a convenient alternative to handwritten prescriptions has evolved into a sophisticated system that leverages the power of technology to improve the entire medication management process. In the early days, e-prescribing systems were relatively basic, primarily focused on eliminating errors caused by illegible handwriting. However, today's e-prescribing solutions are significantly more advanced and provide a multitude of benefits for both healthcare providers and patients.

One of the key technological advancements driving the growth of the e-prescribing market is improved interoperability. Modern e-prescribing systems can seamlessly integrate with electronic health records (EHR) and other healthcare information systems. This integration allows healthcare providers to access a patient's complete medical history, drug allergies, and medication records, ensuring that prescriptions are safer and more accurate. Sophisticated decision support tools integrated into e-prescribing systems assist healthcare providers in making more informed decisions. These tools provide real-time drug interaction alerts, dosage recommendations, and generic drug alternatives, thereby enhancing patient safety and helping to reduce medication errors.

The advent of mobile and cloud-based e-prescribing solutions has made it easier for healthcare providers to create and transmit electronic prescriptions from virtually anywhere. This flexibility not only improves efficiency but also allows for more convenient and timely patient care. The rise of telemedicine has further fueled the adoption of e-prescribing. Telehealth consultations often culminate in the need for a prescription, which can be efficiently generated and transmitted electronically through the same platform, enhancing the patient experience. E-prescribing systems have significantly improved in terms of security features. Encryptions, user authentication, and audit trails ensure that patient data remains secure and compliant with privacy regulations. This reassures both healthcare providers and patients.

Segmental Insights

Product Insights

Based on product, solutions emerged as the fastest growing segment in the global market for e-prescribing in 2023. E-prescribing significantly reduces the chances of prescription errors. The ability to access a patient's complete medical history and drug allergies in real-time allows healthcare providers to make informed decisions, leading to safer patient care. It minimizes the risk of misinterpretation of handwritten prescriptions. E-prescribing systems offer automated reminders and alerts for patients, ensuring that they adhere to their prescribed medication regimens. This feature contributes to better health outcomes and reduces the likelihood of hospital readmissions.

Specialties Insights

Based on specialties, the sports medicine segment is projected to experience rapid growth during the forecast period. Sports medicine is a specialized branch of healthcare that focuses on the prevention, diagnosis, treatment, and rehabilitation of injuries and conditions related to physical activity and sports. It encompasses a wide range of medical disciplines, including orthopedics, physical therapy, sports science, nutrition, and more. As the popularity of sports and physical fitness continues to rise, the demand for sports medicine services has grown significantly.

Athletes frequently encounter injuries that require specialized treatments and medications. E-prescribing simplifies the process of prescribing medications and rehabilitation equipment, allowing sports medicine professionals to quickly and accurately provide the necessary care. This not only accelerates the recovery process but also reduces the risk of medication errors. In the high-pressure world of sports, it is crucial to ensure that athletes receive the right medication at the right time. E-prescribing systems come with safety features, such as drug interaction checks and allergy alerts, that help sports medicine practitioners avoid potentially dangerous medication combinations. E-prescribing promotes better communication between sports medicine practitioners, athletes, and pharmacists. When a prescription is electronically transmitted, the pharmacist can easily access detailed information, enabling them to prepare the medication and equipment more efficiently. This seamless collaboration ensures that athletes receive the most effective treatment.

Regional Insights

Based on region, North America emerged as the dominant region in the Global E-Prescribing Market in 2023, holding the largest market share in terms of value. One of the primary reasons for North America's prominence in the e-prescribing market is the robust regulatory support and framework in place. The United States, in particular, has played a pivotal role in shaping e-prescribing guidelines and standards. The Drug Enforcement Administration (DEA) established the Electronic Prescriptions for Controlled Substances (EPCS) rule, allowing the electronic prescribing of controlled substances, which was a significant milestone in advancing e-prescribing technology. E-prescribing systems significantly enhance patient safety by reducing medication errors, which are a significant concern in healthcare. These systems allow healthcare providers to access patients' medication histories, check for potential drug interactions, and provide accurate dosage information, leading to a decrease in adverse drug events. Patients can also receive their prescriptions directly at the pharmacy, eliminating the need for paper prescriptions that can be lost or misinterpreted. This emphasis on patient safety has been a driving factor behind the adoption of e-prescribing in North America.

Key Market Players

Oracle Corp.

Veradigm LLC

Epic Systems Corporation

Athenahealth, Inc.

NextGen Healthcare, Inc.

McKesson Corporation

Surescripts, LLC

Change Healthcare LLC

Practice Fusion, Inc.

Networking Technology, Inc.

Report Scope:

In this report, the Global E-Prescribing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

E-Prescribing Market, By Product:

    Solutions Services

E-Prescribing Market, By Specialties:

    Oncology Sports Medicine Neurology Cardiology Others

E-Prescribing Market, By Delivery Mode:

    Web/Cloud Based On Premise

E-Prescribing Market, By Substances:

    Controlled Substances Non-controlled Substances

E-Prescribing Market, By Region:

    North America

United States

Canada

Mexico

    Europe

France

United Kingdom

Italy

Germany

Spain

    Asia Pacific

China

India

Japan

Australia

South Korea

    South America

Brazil

Argentina

Colombia

    Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global E-Prescribing Market.

Available Customizations:

Global E-Prescribing Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Global E-Prescribing Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share & Forecast
    • 4.2.1. By Product (Solutions (Integrated Solutions, Standalone Solutions), Services(Support, Implementation, Training, Network)
    • 4.2.2. By Specialties (Oncology, Sports Medicine, Neurology, Cardiology, Others)
    • 4.2.3. By Delivery Mode (Web/Cloud Based, On Premise)
    • 4.2.4. By Substances (Controlled Substances, Non-controlled Substances)
    • 4.2.5. By Region
    • 4.2.6. By Company (2023)
  • 4.3. Market Map
    • 4.3.1. By Product
    • 4.3.2. By Specialties
    • 4.3.3. By Delivery Mode
    • 4.3.4. By Substances
    • 4.3.5. By Region

5. Asia Pacific E-Prescribing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product
    • 5.2.2. By Specialties
    • 5.2.3. By Delivery Mode
    • 5.2.4. By Substances
    • 5.2.5. By Country
  • 5.3. Asia Pacific: Country Analysis
    • 5.3.1. China E-Prescribing Market Outlook
      • 5.3.1.1. Market Size & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share & Forecast
        • 5.3.1.2.1. By Product
        • 5.3.1.2.2. By Specialties
        • 5.3.1.2.3. By Delivery Mode
        • 5.3.1.2.4. By Substances
    • 5.3.2. India E-Prescribing Market Outlook
      • 5.3.2.1. Market Size & Forecast
        • 5.3.2.1.1. By Value
      • 5.3.2.2. Market Share & Forecast
        • 5.3.2.2.1. By Product
        • 5.3.2.2.2. By Specialties
        • 5.3.2.2.3. By Delivery Mode
        • 5.3.2.2.4. By Substances
    • 5.3.3. Australia E-Prescribing Market Outlook
      • 5.3.3.1. Market Size & Forecast
        • 5.3.3.1.1. By Value
      • 5.3.3.2. Market Share & Forecast
        • 5.3.3.2.1. By Product
        • 5.3.3.2.2. By Specialties
        • 5.3.3.2.3. By Delivery Mode
        • 5.3.3.2.4. By Substances
    • 5.3.4. Japan E-Prescribing Market Outlook
      • 5.3.4.1. Market Size & Forecast
        • 5.3.4.1.1. By Value
      • 5.3.4.2. Market Share & Forecast
        • 5.3.4.2.1. By Product
        • 5.3.4.2.2. By Specialties
        • 5.3.4.2.3. By Delivery Mode
        • 5.3.4.2.4. By Substances
    • 5.3.5. South Korea E-Prescribing Market Outlook
      • 5.3.5.1. Market Size & Forecast
        • 5.3.5.1.1. By Value
      • 5.3.5.2. Market Share & Forecast
        • 5.3.5.2.1. By Product
        • 5.3.5.2.2. By Specialties
        • 5.3.5.2.3. By Delivery Mode
        • 5.3.5.2.4. By Substances

6. Europe E-Prescribing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Specialties
    • 6.2.3. By Delivery Mode
    • 6.2.4. By Substances
    • 6.2.5. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. France E-Prescribing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Specialties
        • 6.3.1.2.3. By Delivery Mode
        • 6.3.1.2.4. By Substances
    • 6.3.2. Germany E-Prescribing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Specialties
        • 6.3.2.2.3. By Delivery Mode
        • 6.3.2.2.4. By Substances
    • 6.3.3. Spain E-Prescribing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Specialties
        • 6.3.3.2.3. By Delivery Mode
        • 6.3.3.2.4. By Substances
    • 6.3.4. Italy E-Prescribing Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Product
        • 6.3.4.2.2. By Specialties
        • 6.3.4.2.3. By Delivery Mode
        • 6.3.4.2.4. By Substances
    • 6.3.5. United Kingdom E-Prescribing Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Product
        • 6.3.5.2.2. By Specialties
        • 6.3.5.2.3. By Delivery Mode
        • 6.3.5.2.4. By Substances

7. North America E-Prescribing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Specialties
    • 7.2.3. By Delivery Mode
    • 7.2.4. By Substances
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States E-Prescribing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Specialties
        • 7.3.1.2.3. By Delivery Mode
        • 7.3.1.2.4. By Substances
    • 7.3.2. Mexico E-Prescribing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Specialties
        • 7.3.2.2.3. By Delivery Mode
        • 7.3.2.2.4. By Substances
    • 7.3.3. Canada E-Prescribing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Specialties
        • 7.3.3.2.3. By Delivery Mode
        • 7.3.3.2.4. By Substances

8. South America E-Prescribing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Specialties
    • 8.2.3. By Delivery Mode
    • 8.2.4. By Substances
    • 8.2.5. By Country
  • 8.3. South America: Country Analysis
    • 8.3.1. Brazil E-Prescribing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Specialties
        • 8.3.1.2.3. By Delivery Mode
        • 8.3.1.2.4. By Substances
    • 8.3.2. Argentina E-Prescribing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Specialties
        • 8.3.2.2.3. By Delivery Mode
        • 8.3.2.2.4. By Substances
    • 8.3.3. Colombia E-Prescribing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Specialties
        • 8.3.3.2.3. By Delivery Mode
        • 8.3.3.2.4. By Substances

9. Middle East and Africa E-Prescribing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Specialties
    • 9.2.3. By Delivery Mode
    • 9.2.4. By Substances
    • 9.2.5. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. South Africa E-Prescribing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Specialties
        • 9.3.1.2.3. By Delivery Mode
        • 9.3.1.2.4. By Substances
    • 9.3.2. Saudi Arabia E-Prescribing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Specialties
        • 9.3.2.2.3. By Delivery Mode
        • 9.3.2.2.4. By Substances
    • 9.3.3. UAE E-Prescribing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Specialties
        • 9.3.3.2.3. By Delivery Mode
        • 9.3.3.2.4. By Substances

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

  • 11.1. Recent Developments
  • 11.2. Product Launches
  • 11.3. Mergers & Acquisitions

12. Global E-Prescribing Market: SWOT Analysis

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Product

14. Competitive Landscape

  • 14.1. Oracle Corp.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Product & Services
    • 14.1.4. Financials (In case of listed)
    • 14.1.5. Recent Developments
    • 14.1.6. SWOT Analysis
  • 14.2. Veradigm LLC
  • 14.3. Epic Systems Corporation
  • 14.4. Athenahealth, Inc.
  • 14.5. NextGen Healthcare, Inc.
  • 14.6. McKesson Corporation
  • 14.7. Surescripts, LLC
  • 14.8. Change Healthcare LLC
  • 14.9. Practice Fusion, Inc.
  • 14.10.Networking Technology, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer